Development code · Biologic
RO4909832
RO4909832 is a development code for Gantenerumab, developed by F. Hoffmann-La Roche Ltd.
- Status
- Discontinued for Alzheimer's disease
- Mechanism
- Amyloid-beta (aggregated) Inhibitor
- Developer
- F. Hoffmann-La Roche Ltd
Programs
- Gantenerumab for Alzheimer's diseaseDiscontinuedDiscontinued
Also known as
- RG1450
- R1450
- RO-4909832
- RG-1450
- gantenerumab
- 1043556-46-2